Epirium Bio
PrivateLast Round
Series B
Jul 25, 2025
Total Funding Raised
$85M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Epirium Bio operates in Healthcare & Life Sciences and is based in San Diego, California. Its latest recorded funding round was a Series A round in December 2019.
Epirium Bio is a biopharmaceutical company that develops therapeutic drugs aimed at treating diseases associated with mitochondrial depletion and dysfunction.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Epirium Bio Comparables
Compare Epirium Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NMD Pharma | 76% | |
| Rejuvenate Biomed | 75% | |
| ImmunoForge Co., Ltd. | 75% |
For institutional investors. Book with your work email.
Epirium Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jul 25, 2025 | ||||
| Series A | Dec 18, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Epirium Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Longitude Capital | Series A |
| Vertex Ventures HC | Series A |
| ARCH Venture Partners | Series A |
| Bluebird Ventures | Series A |
| The Longevity Fund | Series A |
| Adams Street Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 33% MoM.
- Jun 20, 2026
Monthly visitors increased 30% MoM, reaching 4.6K.
For institutional investors. Book with your work email.
Epirium Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Epirium Bio's valuation, stock price, and market status.
Is Epirium Bio a public or private company?
Epirium Bio is a private company.
What is the current stock price of Epirium Bio?
Epirium Bio is a private company, so its shares have no public market price. Caplight tracks Epirium Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Epirium Bio worth (valuation)?
Valuation information for Epirium Bio is not publicly available.
Can I buy Epirium Bio stock?
Epirium Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Epirium Bio's last funding round?
Epirium Bio's most recent funding round was Series B on July 25, 2025.
Who are the main investors in Epirium Bio?
Key investors in Epirium Bio include Longitude Capital, ARCH Venture Partners.
Will Epirium Bio IPO soon?
No public IPO plans have been announced for Epirium Bio.
How can I track Epirium Bio secondary market activity?
Caplight tracks bids, offers, and trades in Epirium Bio's shares on secondary markets.